Journal of Clinical Oncology | 2019
Prevalence and molecular etiology of mismatch repair deficiency among gastrointestinal cancers.
Abstract
215Background: In light of recent FDA approval of anti-PD-1 therapy for microsatellite unstable (MSI-H) or mismatch repair deficient (dMMR) solid tumors, identifying patients with dMMR tumors has b...